期刊档案 · 医学-肿瘤学
Asian Pacific Journal of Cancer Prevention
ISSN 1513-7368 · eISSN 2476-762X · Asian Pacific Organization for Cancer Prevention · JAPAN · Quarterly · 创刊 2000
Asian Pacific Journal of Cancer Prevention 完全开放获取，APC 约 400 美元，投稿社区反馈审稿约 3 个月，录用比例约63.57%（社区反馈），2025 年发文 532 篇，Scopus 收录。
研究范围
研究范围与定位
Asian Pacific Journal of Cancer Prevention 由 Asian Pacific Organization for Cancer Prevention 出版。按 OpenAlex 近年发文统计，该刊主要发表 Global Cancer Incidence and Screening、Women's cancer prevention and management、Head and Neck Cancer Studies 等主题的论文，这 3 个主题约占 26.3%，主导子领域为 Oncology。（根据 OpenAlex 主题统计与中科院分区数据生成）
Cancer is a very complex disease. While many aspects of carcinogens and oncogenes are known, cancer control and prevention at the community level is still an emerging science and discipline. Much more work needs to be done, and many more steps need to be taken before effective strategies are developed. The multidisciplinary approaches and efforts to understand and control cancer in an effective and efficient manner, require highly trained scientists in all branches of the cancer sciences, from cellular and molecular aspects to patient care and palliation. The Asia Pacific Organization for Cancer Prevention (APOCP) and its official publication, the Asia Pacific Journal of Cancer Prevention (APJCP), have served the community of cancer scientists very well and intend to continue to serve in this capacity to the best of their abilities. One of the main missions of APOCP is to provide a forum for communication and propagation of original and innovative research findings that have relevance to understanding the etiology, progression, treatment, and survival of patients. This mission has been met with its journals, especially its flagship journal APJCP. The APJCP with its distinguished, diverse, and Asia-wide team of editors, reviewers, and readers, ensures the highest standards of research communication within the cancer sciences community across Asia as well as globally. The APJCP publishes original research results under the following categories: Epidemiology, early detection, and screening, risk factors and etiology of cancer. Cellular research and bio-markers/ Biochemical and pathophysiological aspects related to cancer and cell malignancy, Oxidative stress, apoptosis, etc. Identification of bio-targets and agents with novel mechanisms of action. Optimal clinical use of existing anti-cancer agents, including combination therapies. Chemotherapy Radiation and surgery. Palliative care. Patient care, quality of life, satisfaction. Health economic evaluations. Smoking, smoking-related complications at cellular and organ level Smoking-related behavior, social, and psychological aspects Tobacco-related products (chewing, vaping, etc..) and their effect on micro (cellular) and Macro (organ) Alternative medicine in cancer
摘自期刊官网 Aims & Scope
研究方向（LetPub）：医学-肿瘤学
主编 Alireza Mosavi Jarrahi出版商官网
编委会国家分布：中国大陆 1 位（约 2%）；主要国家 伊朗 13、日本 5、印度 5、韩国 2、澳大利亚 2（共 41 位编委标注了国家） 编委会 ↗出版商官网 ·
主要研究主题 OpenAlex 近年发文统计，占比为近似值
- Global Cancer Incidence and ScreeningMedicine11.2%
- Women's cancer prevention and managementMedicine7.8%
- Head and Neck Cancer StudiesMedicine7.3%
- Cervical Cancer and HPV ResearchMedicine7%
- Breast Cancer Treatment StudiesBiochemistry, Genetics and Molecular Biology5.6%
- Genetic Associations and EpidemiologyBiochemistry, Genetics and Molecular Biology5.1%
- Gastric Cancer Management and OutcomesMedicine4.1%
- Breast Lesions and CarcinomasMedicine3.9%
分区与收录
学科分区与数据库收录
中科院期刊分区表
期刊分区表（ 2025年3月升级版）未收录
该期刊未被此版本分区表收录。
《新锐期刊分区表》（ 2026年3月发布）未收录
该期刊未被此版本分区表收录。
期刊分区表（ 2023年12月旧的升级版）未收录
该期刊未被此版本分区表收录。
CiteScore 分区（Scopus，2026 年 6 月版）
| 学科 | 分区 | 排名 | 百分位 |
|---|---|---|---|
| Public Health, Environmental and Occupational Health | Q2 | 333/725 | 54% |
| Epidemiology | Q2 | 87/173 | 50% |
| Oncology | Q3 | 258/428 | 39% |
| Cancer Research | Q4 | 176/233 | 24% |
Scopus 按 CiteScore 在每个学科内为期刊排名，百分位 75 及以上为 Q1，每 25 为一档；与中科院分区是不同体系。LetPub
数据库收录
ScopusDOAJLetPub
国际期刊预警名单：各版本均未列入LetPub
期刊官网自述收录
MEDLINEPMCEmbase出版商官网
期刊官网列出的收录清单，未与各数据库逐一核对；Web of Science 各子库以上方记录为准。
不同版本、大类与小类分别展示，不将不同评价口径合并为一个分区值；投稿与考核前请确认所在机构采用的版本。
指标
影响力指标与发文规模
影响力指标
- CiteScore 2026-06
- 3.1LetPub ·
- SJR 2026-06
- 0.5LetPub ·
- SNIP 2026-06
- 0.67LetPub ·
- h-index
- 65LetPub ·
- h-index
- 100OpenAlex ·
- i10-index
- 5,396OpenAlex ·
- 两年平均被引
- 1.91OpenAlex ·
- Gold OA 文章占比
- 0%LetPub ·
发文规模
- 年文章数
- 1,385LetPub ·
逐年发文量 OpenAlex 统计 · 累计 10,276 篇 · 当年数据不完整
| 年份 | 发文量 | 其中 OA | 被引 |
|---|---|---|---|
| 2026 | 437 | 437 | 9,228 |
| 2025 | 532 | 532 | 13,330 |
| 2024 | 513 | 513 | 15,525 |
| 2023 | 519 | 519 | 15,420 |
| 2022 | 516 | 516 | 16,052 |
| 2021 | 520 | 520 | 15,495 |
不同来源的统计口径与观测时间不同，页面保留各来源原值；“出版商公布”为期刊官网自述数据。
审稿与录用
审稿周期与录用情况
- 平均审稿速度（社区反馈）
- 平均3.0个月LetPub ·
- 平均录用比例（社区反馈）
- 63.57%LetPub ·
- 投稿到发表（期刊自报）
- 约 6 周DOAJ ·
- 评审方式
- 单盲同行评审DOAJ
社区反馈来自投稿者样本，置信度 0.5，不代表期刊承诺；“出版商公布”的时间节点定义以官网为准。
费用与开放获取
版面费与开放获取政策
完全开放获取DOAJ
所有文章开放获取，通常向作者收取文章处理费（APC）。
| 来源 | 文章处理费 | 费用减免 | 许可证 | 观测时间 |
|---|---|---|---|---|
| DOAJ | USD 400 | 有 | CC BY | |
| OpenAlex | USD 200 | — | — | |
| LetPub | USD 200 | 有 | — | |
| 出版商官网 | USD 250 / USD 275 / USD 375 / USD 550 / USD 50 | — | — |
其他费用与减免（作者指南）
- 投稿费
- USD 250
- APC 费用说明 ↗DOAJ
- 费用减免政策 ↗DOAJ
- 开放获取声明 ↗DOAJ
- 许可与版权 ↗DOAJ
费用以期刊官网为准；不同来源的观测时间可能不同，页面保留各来源原值，不做平均。
投稿要求
文章类型与投稿政策（官网）
投稿准备要点7 项，摘自作者指南
- 摘要
- ≤ 300 词
- 关键词
- 3–10 个
- 正文篇幅
- ≤ 5,000 词
- 参考文献格式
- Vancouver 格式
- 首次投稿格式
- 允许不按期刊格式排版（free format）
- 推荐审稿人
- 必须提供 2 位
- 不接收
- presubmission inquiries
接收的文章类型22 种，含篇幅限制
- case seriesCase series: Reports of single cases will not be considered; however, the APJCP encourages large case series from Asian countries/populations未说明篇幅
- commentariesCommentaries: Presents a point of view of general interest not related to an article in the same issue of the APJCP.未说明篇幅
- commentaryThe APJCP accepts the following manuscript types: Research Articles: Scientific reports of original research. The text for research articles is limited to 5,000…未说明篇幅
- correspondenceCorrespondence: Letters to the Editor related to papers previously published in the APJCP.未说明篇幅
- editorialThe APJCP accepts the following manuscript types: Research Articles: Scientific reports of original research. The text for research articles is limited to 5,000…未说明篇幅
- editorialsEditorials: Opinions of recognized leaders in cancer specialties.未说明篇幅
- in memoriamIn Memoriam: Memorialization of recently deceased individuals who have made notable contributions to the field of cancer prevention in the Asia Pacific region.未说明篇幅
- meta-analysisThe APJCP accepts the following manuscript types: Research Articles: Scientific reports of original research. The text for research articles is limited to 5,000…未说明篇幅
- methodological papersMethodological papers: Manuscripts containing a description of novel methods and significant improvements to tried-and-tested basic research techniques related …未说明篇幅
- opinionThe APJCP accepts the following manuscript types: Research Articles: Scientific reports of original research. The text for research articles is limited to 5,000…未说明篇幅
- original paperThe APJCP accepts the following manuscript types: Research Articles: Scientific reports of original research. The text for research articles is limited to 5,000…正文 ≤ 2,000 词
- original researchThe APJCP accepts the following manuscript types: Research Articles: Scientific reports of original research. The text for research articles is limited to 5,000…未说明篇幅
- protocolProtocol: Manuscripts of ongoing or starting large, well-designed studies, such as clinical trials and cohorts, can be considered for publication if the manuscr…未说明篇幅
- research articleThe APJCP accepts the following manuscript types: Research Articles: Scientific reports of original research. The text for research articles is limited to 5,000…正文 ≤ 5,000 词
- research articlesResearch Articles: Scientific reports of original research.未说明篇幅
- reviewThe APJCP accepts the following manuscript types: Research Articles: Scientific reports of original research. The text for research articles is limited to 5,000…未说明篇幅
- review articleThe APJCP accepts the following manuscript types: Research Articles: Scientific reports of original research. The text for research articles is limited to 5,000…未说明篇幅
- review articles, including mini-reviewReview Articles, including mini-review: A timely, in-depth treatment of an issue.未说明篇幅
- short communicationThe APJCP accepts the following manuscript types: Research Articles: Scientific reports of original research. The text for research articles is limited to 5,000…未说明篇幅
- short communicationsShort Communications: Short scientific report on selected topics from recognized cancer organizations or associations.未说明篇幅
- systematic reviewThe APJCP accepts the following manuscript types: Research Articles: Scientific reports of original research. The text for research articles is limited to 5,000…未说明篇幅
- systematic review and meta-analysisSystematic Review and Meta-analysis: A systematic review answers a defined research question by collecting and summarizing all empirical evidence that fits pre-…未说明篇幅
官网政策摘录作者资格、利益冲突、出版伦理、许可与版权、同行评审
- 作者资格 Authorship Responsibility
作者署名表示每位作者充分参与了工作并对内容承担公共责任，署名应基于以下标准：对研究构思设计或分析解释有实质性贡献、批判性参与修改论文的学术内容、批准最终版本，并对工作的所有方面承担责任。 模型中文摘要
The authors’ names listed in a manuscript indicate that each author has participated sufficiently in the work to take public responsibility for the content. Authorship should be established based on the following criteria and responsibilities: Substantial contributions to conception and design, or analysis and interpretation of research. Participate critically in revising the intellectual contents…
原文 ↗出版商官网 ·- 利益冲突
APJCP 不考虑任何直接或间接由烟草公司或其子公司资助的工作，此类工作将被编辑拒稿。 模型中文摘要
The APJCP will not consider any work that is funded directly or indirectly by tobacco companies or their subsidiaries. Any such work will be editorially rejected.
原文 ↗出版商官网 ·- 出版伦理
APJCP 要求所有前瞻性随机对照试验在国家或国际注册数据库中注册。 模型中文摘要
The APJCP requires that all prospective, randomized, controlled trials be registered in a national or international registry database.
原文 ↗出版商官网 ·- 许可与版权
发表于《亚太癌症预防杂志》的所有稿件均采用知识共享署名许可条款。 模型中文摘要
All manuscripts published in the Asia Pacific Journal of Cancer Prevention, are under the terms of the Creative Commons Attribution License.
原文 ↗出版商官网 ·- 同行评审
APJCP 不考虑同时投给其他期刊或已发表（包括在线发表）的稿件。 模型中文摘要
The APJCP will not consider manuscripts that are concurrently submitted elsewhere or have been published previously (including online publications).
原文 ↗出版商官网 ·
摘录来自期刊官网页面，仅保留原文片段；“模型摘要”由 Workers AI 生成并经原文校验，以官网为准。
基本信息
出版信息与官方入口
- 出版商
- Asian Pacific Organization for Cancer Prevention
- 出版国家或地区
- JAPAN
- 出版语言
- English
- 出版周期
- Quarterly
- 创刊年份
- 2000
- ISSN
- 1513-7368
- 电子版 ISSN
- 2476-762X
- 学会 / 主办单位
- Asian Pacific Organization for Cancer Prevention
- 官网最新一期
- Volume 27, Issue 8（2026 年）
- 官方链接
- 期刊主页 ↗OpenAlex
- 投稿系统 ↗LetPub
- 作者指南 ↗LetPub
- Aims & Scope ↗LetPub
- APC 费用说明 ↗DOAJ
- 费用减免政策 ↗DOAJ
- 开放获取声明 ↗DOAJ
- 许可与版权 ↗DOAJ
- 评审流程 ↗LetPub
- 编委会 ↗LetPub
常见问题
关于 Asian Pacific Journal of Cancer Prevention 的常见问题
Asian Pacific Journal of Cancer Prevention 的审稿周期多长？
投稿社区反馈的平均审稿速度为约 3 个月，平均录用比例反馈为“约63.57%”。文章统计只含被录用的稿件，出版商数据口径以官网为准，社区反馈来自投稿者样本，均不代表期刊承诺。
Asian Pacific Journal of Cancer Prevention 的投稿格式要求是什么？
据期刊作者指南：摘要：≤ 300 词；关键词：3–10 个；正文篇幅：≤ 5,000 词；参考文献格式：Vancouver 格式；首次投稿格式：允许不按期刊格式排版（free format）；推荐审稿人：必须提供 2 位。以上由模型从作者指南提取并逐项与原文核对，投稿前请以官网最新版本为准。
Asian Pacific Journal of Cancer Prevention 的编委会里有中国学者吗？
期刊官网编委会页面上标注了国家的 41 位编委中，中国大陆 1 位（约 2%）；人数最多的国家是 伊朗（13 位）、日本（5 位）、印度（5 位）。统计按编委会页面列出的机构国家计，仅供参考。
Asian Pacific Journal of Cancer Prevention 被哪些数据库收录？
据 LetPub 与 DOAJ 记录，Asian Pacific Journal of Cancer Prevention 被 Scopus、DOAJ 收录。期刊官网自述还被 MEDLINE、PMC、Embase 收录，该清单未与各数据库逐一核对。
Asian Pacific Journal of Cancer Prevention 是开放获取期刊吗？版面费多少？
Asian Pacific Journal of Cancer Prevention 为完全开放获取。APC 约 400 美元。
来源与更新
本页事实来自 LetPub、OpenAlex、DOAJ、出版商官网；每个数字旁标注来源与观测日期，冲突数据保留各来源原值。LetPub 原始详情页：查看 ↗（2026-08-25 归档）。最近更新：。